Piramal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DK501011
  • NSEID: PPLPHARMA
  • BSEID: 543635
INR
239.25
-0.15 (-0.06%)
BSENSE

Nov 20

BSE+NSE Vol: 41.12 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "239.25",
    "chg": -0.15,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "239.40",
    "mcapval": "31,833.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DK501011",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "41.12 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-hold-by-marketsmojo-4256829",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PiramalPharmaLt_mojoScore_4256829.png",
        "date": "2026-11-09 10:10:04",
        "description": "Piramal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 October 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Piramal Pharma Ltd to 52-Week High of Rs 250.3",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-ltd-hits-new-52-week-high-at-rs2503-4256506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PiramalPharmaLt_priceRelatedfactors_4256506.png",
        "date": "2026-11-09 09:51:26",
        "description": "Trading above all major moving averages and buoyed by a string of positive technical signals, Piramal Pharma Ltd surged to a new 52-week high of Rs 250.3 on 09 Nov 2026, marking a significant milestone in its price momentum journey."
      },
      {
        "title": "Piramal Pharma Gains 0.06%: 2 Key Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-gains-006-2-key-factors-driving-the-week-4255040",
        "imagepath": "",
        "date": "2026-11-07 12:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> New 52-week high at Rs.241.85</p>\n                    <p><strong>Nov 3:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>Nov 6:</strong> Week closes at Rs.239.20 (+0.06%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.239.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.239.20</div><div class=\"stat-change positive\">+0.06%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week High</div><div ..."
      },
      {
        "title": "Piramal Pharma Surges 25.26%: 5 Key Drivers Behind the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-surges-2526-5-key-drivers-behind-the-rally-4245597",
        "imagepath": "",
        "date": "2026-10-31 12:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Technical momentum shifts amid mixed signals</p>\n                    <p><strong>27 Oct:</strong> Mojo Grade upgraded from Strong Sell to Sell</p>\n                    <p><strong>28 Oct:</strong> New 52-week high at Rs.232.95 and strong quarterly turnaround</p>\n                    <p><strong>29 Oct:</strong> New 52-week high at Rs.239.4 and quality grade upgrade</p>\n                    <p><strong>30 Oct:</strong> New 52-week high at Rs.239.5 closes week on a strong note</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                       ..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Piramal Pharma Ltd to 52-Week High of Rs 239.5",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-ltd-hits-new-52-week-high-at-rs2395-4244875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_priceRelatedfactors_4244875.png",
        "date": "2026-10-30 11:36:43",
        "description": "Surging to an intraday peak of Rs 239.5 on 30 Oct 2026, Piramal Pharma Ltd has marked a significant milestone by reaching its highest price in the past 52 weeks. This advance comes amid a backdrop of sustained technical momentum and outperformance relative to its sector and the broader market."
      },
      {
        "title": "Piramal Pharma Ltd Quality Grade Upgrade Signals Improving Fundamentals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-ltd-quality-grade-upgrade-signals-improving-fundamentals-4242578",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_qualitydot_4242578.png",
        "date": "2026-10-29 08:00:09",
        "description": "Piramal Pharma Ltd has seen its quality grade upgraded from below average to average, reflecting notable improvements in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), and debt management. This upgrade accompanies a strong share price rally, underscoring renewed investor confidence amid a challenging pharmaceutical sector backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Piramal Pharma Ltd to 52-Week High of Rs 232.95",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-ltd-hits-new-52-week-high-at-rs23295-4242329",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_priceRelatedfactors_4242329.png",
        "date": "2026-10-28 12:37:22",
        "description": "Surging to a fresh 52-week high of Rs 232.95 on 28 Oct 2026, Piramal Pharma Ltd has demonstrated remarkable price momentum, outperforming its sector by 15.65% in a single session and extending gains over three consecutive days for a total return of 21.09%. This rally unfolds amid a broader market environment where the Sensex trades near its 52-week low, underscoring the stock’s distinctive strength."
      },
      {
        "title": "Piramal Pharma Ltd Reports Strong Quarterly Turnaround Amid Market Outperformance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-ltd-reports-strong-quarterly-turnaround-amid-market-outperformance-4242233",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_fintrenddot_4242233.png",
        "date": "2026-10-28 11:00:14",
        "description": "Piramal Pharma Ltd has demonstrated a significant financial turnaround in the quarter ended September 2026, reversing previous negative trends with robust revenue growth and margin expansion. The company’s stock surged 13.25% on 28 Oct 2026, reflecting renewed investor confidence amid a broader market rally."
      },
      {
        "title": "Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Strong Price Gains",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/piramal-pharma-ltd-sees-exceptional-volume-surge-amid-strong-price-gains-4241696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_most_active_equities_by_volume_4241696.png",
        "date": "2026-10-28 10:00:16",
        "description": "Piramal Pharma Ltd (PPLPHARMA) has emerged as one of the most actively traded stocks by volume on 28 Oct 2026, registering a remarkable 13.35% gain in a single day. The pharmaceutical and biotechnology company’s shares surged on robust trading volumes, signalling renewed investor interest and a potential shift in market sentiment despite a recent downgrade in its Mojo Grade."
      }
    ],
    "total": 108,
    "sid": "1003728",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/piramal-pharma-1003728"
  },
  "announcements": [
    {
      "caption": "Exercise Of Call Option To Acquire The Balance 26% Equity Stake In Yapan Bio Private Limited.",
      "datetime": "18-Nov-2026",
      "details": "Please find enclosed intimation of the exercise of call option to acquire the balance 26% equity stake in Yapan Bio Private Limited.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "31-Oct-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "30-Oct-2026",
      "details": "Please find enclosed details of Earning call Transcript held on 28th October 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Exercise Of Call Option To Acquire The Balance 26% Equity Stake In Yapan Bio Private Limited.

18-Nov-2026 | Source : BSE

Please find enclosed intimation of the exercise of call option to acquire the balance 26% equity stake in Yapan Bio Private Limited.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

31-Oct-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

30-Oct-2026 | Source : BSE

Please find enclosed details of Earning call Transcript held on 28th October 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Piramal Pharma Ltd has declared 1% dividend, ex-date: 16 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Piramal Pharma Ltd has announced 5:46 rights issue, ex-date: 02 Aug 23